{"id":114796,"date":"2024-07-17T13:44:00","date_gmt":"2024-07-17T06:44:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/20240717134400114796"},"modified":"2024-07-18T03:57:53","modified_gmt":"2024-07-17T19:57:53","slug":"%e7%9b%9f%e7%a7%91%e8%8d%af%e4%b8%9a%e5%9c%a8%e7%ac%ac%e4%b8%83%e5%b1%8a%e4%b8%96%e7%95%8c%e6%94%af%e6%b0%94%e7%ae%a1%e6%89%a9%e5%bc%a0%e7%97%87%e5%a4%a7%e4%bc%9a%e4%b8%8a%e5%b1%95%e7%a4%ba%e5%88%9b","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/20240717134400114796","title":{"rendered":"\u76df\u79d1\u836f\u4e1a\u5728\u7b2c\u4e03\u5c4a\u4e16\u754c\u652f\u6c14\u7ba1\u6269\u5f20\u75c7\u5927\u4f1a\u4e0a\u5c55\u793a\u521b\u65b0\u6297\u751f\u7d20\u7814\u7a76\u7ed3\u679c"},"content":{"rendered":"<ul type=\"disc\">\n<li>\u76df\u79d1\u836f\u4e1a\u5728\u7b2c\u4e03\u5c4a\u4e16\u754c\u652f\u6c14\u7ba1\u6269\u5f20\u75c7\u5927\u4f1a\u4e0a\uff0c\u5c55\u793a\u4e86\u516c\u53f8\u7ba1\u7ebf\u4ea7\u54c1MRX-8\u548cMRX-5\u7684\u6700\u65b0\u7814\u7a76\u8fdb\u5c55<\/li>\n<li>\u4e09\u9879\u91cd\u8981\u7814\u7a76\u7ed3\u679c\u8fdb\u4e00\u6b65\u652f\u6301\u4e86MRX-8\u548cMRX-5\u5728<b>\u6cbb\u7597\u975e\u7ed3\u6838\u5206\u679d\u6746\u83cc\u80ba\u75c5\u548c\u94dc\u7eff\u5047\u5355\u80de\u83cc\u611f\u67d3\u7684\u6f5c\u529b<\/b><\/li>\n<\/ul>\n<p><p><span class=\"legendSpanClass\">\u82cf\u683c\u5170\u9093\u8fea<\/span><span class=\"legendSpanClass\">2024\u5e747\u670817\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; \u4e0a\u6d77\u76df\u79d1\u836f\u4e1a\u80a1\u4efd\u6709\u9650\u516c\u53f8\uff08&quot;\u76df\u79d1\u836f\u4e1a&quot;\uff0c688373.SH\uff09\u4e8e2024\u5e747\u67084\u65e5\u81f36\u65e5\u5728\u82cf\u683c\u5170\u9093\u8fea\u4e3e\u884c\u7684\u7b2c\u4e03\u5c4a\u4e16\u754c\u652f\u6c14\u7ba1\u6269\u5f20\u75c7\u5927\u4f1a\uff08World Bronchiectasis Conference\uff0cWBC\uff09\u4e0a\uff0c\u5c55\u793a\u4e86\u516c\u53f8\u5728\u7814\u7684\u65b0\u578b\u6297\u751f\u7d20\u7ba1\u7ebf\u4ea7\u54c1MRX-8\u548cMRX-5\u7684\u6700\u65b0\u7814\u7a76\u8fdb\u5c55\u3002\u8fd9\u4e9b\u7814\u7a76\u7ed3\u679c\u4e3a\u672a\u6765\u6cbb\u7597\u975e\u7ed3\u6838\u5206\u679d\u6746\u83cc\uff08Nontuberculous Mycobacterial\uff0cNTM\uff09\u80ba\u75c5\u548c\u94dc\u7eff\u5047\u5355\u80de\u83cc\u611f\u67d3\u63d0\u4f9b\u4e86\u65b0\u7684\u5e0c\u671b\u3002<\/p>\n<p><b>\u5927\u4f1a\u80cc\u666f<\/b><\/p>\n<p>\u4e16\u754c\u652f\u6c14\u7ba1\u6269\u5f20\u75c7\u5927\u4f1a\u662f\u5168\u7403\u9886\u5148\u7684\u4e13\u6ce8\u4e8e\u652f\u6c14\u7ba1\u6269\u5f20\u75c7\u7814\u7a76\u548c\u6cbb\u7597\u7684\u5b66\u672f\u4f1a\u8bae\u3002\u672c\u6b21\u5927\u4f1a\u6c47\u96c6\u4e86\u5168\u7403\u9876\u5c16\u7684\u79d1\u5b66\u5bb6\u548c\u4e34\u5e8a\u4e13\u5bb6\uff0c\u5171\u540c\u63a2\u8ba8\u652f\u6c14\u7ba1\u6269\u5f20\u75c7\u7684\u6700\u65b0\u7814\u7a76\u8fdb\u5c55\u3001\u4e34\u5e8a\u7ba1\u7406\u7b56\u7565\u4ee5\u53ca\u65b0\u7597\u6cd5\u7684\u5f00\u53d1\u3002<\/p>\n<p><b>\u7814\u7a76\u4eae\u70b9<\/b><\/p>\n<p>\u4f5c\u4e3a\u81f4\u529b\u4e8e\u5f00\u53d1\u521b\u65b0\u6297\u611f\u67d3\u836f\u7269\u7684\u751f\u7269\u533b\u836f\u4f01\u4e1a\uff0c\u76df\u79d1\u836f\u4e1a\u5728\u5927\u4f1a\u4e0a<b>\u4ee5\u58c1\u62a5\u5f62\u5f0f\u5c55\u793a\u4e86\u4e09\u9879\u91cd\u8981\u7814\u7a76\u7ed3\u679c\uff0c\u8fd9\u4e9b\u7814\u7a76\u8fdb\u4e00\u6b65\u652f\u6301\u4e86<\/b><b>MRX-8\u548cMRX-5\u5728\u6cbb\u7597<\/b><b>\u7279\u5b9a\u611f\u67d3\u65b9\u5411<\/b><b>\u7684\u6f5c\u529b<\/b>\uff1a<\/p>\n<ul type=\"disc\">\n<li>\u65b0\u578b\u591a\u9ecf\u83cc\u7d20\u6297\u751f\u7d20\u5bf9\u94dc\u7eff\u5047\u5355\u80de\u83cc\u7684\u4f53\u5916\u548c\u4f53\u5185\u6d3b\u6027\u7814\u7a76\uff08In vitro and in vivo activity of a novel antibiotic in the polymyxin class against Pseudomonas aeruginosa\uff09<\/li>\n<\/ul>\n<p>MRX-8\u5bf9\u94dc\u7eff\u5047\u5355\u80de\u83cc\uff08\u5305\u62ec\u5bf9\u59a5\u5e03\u9709\u7d20\u548c\u963f\u7c73\u5361\u661f\u8010\u836f\u7684\u4e34\u5e8a\u5206\u79bb\u682a\uff09\u8868\u73b0\u51fa\u5f3a\u6548\u4f53\u5916\u6297\u83cc\u6d3b\u6027\u3002\u5728\u94dc\u7eff\u5047\u5355\u80de\u83cc\u80ba\u90e8\u611f\u67d3\u7684\u5c0f\u9f20\u6a21\u578b\u4e2d\uff0c\u5305\u62ec\u5bf9\u59a5\u5e03\u9709\u7d20\u654f\u611f\u548c\u8010\u836f\u7684\u5206\u79bb\u682a\uff0c\u901a\u8fc7\u96fe\u5316\u5438\u5165MRX-8\u6cbb\u7597\uff0c\u663e\u8457\u51cf\u5c11\u4e86\u80ba\u7ec4\u7ec7\u4e2d\u7684\u7ec6\u83cc\u8d1f\u8377\uff0c\u8868\u73b0\u51fa\u6740\u83cc\u6d3b\u6027\u3002<\/p>\n<ul type=\"disc\">\n<li>\u65b0\u578b\u4eae\u6c28\u9170-tRNA\u5408\u6210\u9176\u6291\u5236\u5242\u5bf9\u9e1f\u5206\u679d\u6746\u83cc\u590d\u5408\u7fa4\u7684\u4f53\u5916\u6d3b\u6027\u7814\u7a76\uff08In Vitro Activity of Novel Leucyl-tRNA Synthetase Inhibitor Against Mycobacterium Avium Complex\uff09<\/li>\n<\/ul>\n<p>MRX-6038\uff08MRX-5\u4e3b\u8981\u6d3b\u6027\u4ee3\u8c22\u4ea7\u7269\uff09\u5bf9\u9e1f\u5206\u679d\u6746\u83cc\u4e34\u5e8a\u5206\u79bb\u682a\uff08\u5305\u62ec\u5bf9\u514b\u62c9\u9709\u7d20\u4e0d\u654f\u611f\u7684\u5206\u79bb\u682a\uff09\u8868\u73b0\u51fa\u5f3a\u6548\u4f53\u5916\u6297\u83cc\u6d3b\u6027\u3002\u5f53MRX-6038\u4e0e\u514b\u62c9\u9709\u7d20\u3001\u5229\u798f\u5e03\u6c40\u3001\u963f\u7c73\u5361\u661f\u548c\u4e59\u80fa\u4e01\u9187\u8054\u5408\u4f7f\u7528\u65f6\uff0c\u8fd9\u4e9b\u6807\u51c6\u6cbb\u7597\u836f\u7269\u7684\u8010\u836f\u9891\u7387\u5927\u5e45\u964d\u4f4e\u81f3\u4f4e\u4e8e6.5 &times; 10<sup>-11<\/sup>\u3002\u5bf9MRX-6038\u6cbb\u7597\u5206\u679d\u6746\u83cc\u80ba\u75c5\u7684\u8bc4\u4f30\u5c1a\u9700\u8fdb\u4e00\u6b65\u7814\u7a76\u3002<\/p>\n<ul type=\"disc\">\n<li>\u65b0\u578b\u4eae\u6c28\u9170-tRNA\u5408\u6210\u9176\u6291\u5236\u5242\u5bf9\u8113\u80bf\u5206\u679d\u6746\u83cc\u7684\u4f53\u5916\u548c\u4f53\u5185\u6d3b\u6027\u7814\u7a76\uff08In vitro and In vivo activity of a novel Leucyl-tRNA synthetase inhibitor against Mycobacterium abscessus\uff09<\/li>\n<\/ul>\n<p>MRX-6038\u5bf9\u8113\u80bf\u5206\u679d\u6746\u83cc\u4e34\u5e8a\u5206\u79bb\u682a\u8868\u73b0\u51fa\u6781\u5f3a\u7684\u4f53\u5916\u6297\u83cc\u6d3b\u6027\uff0c\u5176MIC<sub>90<\/sub>\u4e3a0.5 mg\/L\uff0c\u800c\u5bf9\u7167\u836f\u7269\u514b\u62c9\u9709\u7d20\u7684MIC<sub>90<\/sub>\u4e3a4 mg\/L\u3002MRX-6038\u5927\u5e45\u964d\u4f4e\u4e86\u6807\u51c6\u6cbb\u7597\u836f\u7269\uff08\u4e59\u80fa\u4e01\u9187\u3001\u514b\u62c9\u9709\u7d20\u3001\u5229\u798f\u5e03\u6c40\u3001\u6c2f\u6cd5\u9f50\u660e\u3001\u963f\u7c73\u5361\u661f\u3001\u4e9a\u80fa\u57f9\u5357\u3001\u73af\u4e19\u6c99\u661f\uff09\u7684\u8010\u836f\u9891\u7387\uff0c\u964d\u5e45\u8d85\u8fc710\u81f3100000\u500d\uff0c\u663e\u793a\u51fa\u4e0e\u80cc\u666f\u7597\u6cd5\u8054\u5408\u4f7f\u7528\u7684\u6f5c\u529b\u3002\u53e3\u670d\u524d\u836fMRX-5\u5728\u8113\u80bf\u5206\u679d\u6746\u83cc\u5206\u79bb\u682a\u5f15\u8d77\u80ba\u90e8\u611f\u67d3\u7684\u5c0f\u9f20\u4e2d\u8fdb\u884c\u4e86\u6d4b\u8bd5\uff0c\u7ed3\u679c\u663e\u793a\u5176\u5bf9\u514b\u62c9\u9709\u7d20\u654f\u611f\u548c\u4e0d\u654f\u611f\u5206\u79bb\u682a\u5f15\u8d77\u7684\u7684\u611f\u67d3\u5747\u5177\u6709\u7597\u6548\u3002<\/p>\n<p><b>\u5173\u4e8e<\/b><b>MRX-8<\/b><\/p>\n<p>MRX-8\u662f\u7531\u76df\u79d1\u836f\u4e1a\u81ea\u4e3b\u7814\u53d1\u7684\u4e00\u79cd\u65b0\u578b\u6ce8\u5c04\u7528\u591a\u9ecf\u83cc\u7d20\u7c7b\u6297\u83cc\u836f\uff0c\u4e3b\u8981\u7528\u4e8e\u6cbb\u7597\u7531\u591a\u91cd\u8010\u836f\u9769\u5170\u9634\u6027\u83cc\u5f15\u8d77\u7684\u4e25\u91cd\u611f\u67d3\u3002\u5728\u4f20\u7edf\u591a\u9ecf\u83cc\u7d20\u7c7b\u836f\u7269\u56e0\u80be\u6bd2\u6027\u548c\u795e\u7ecf\u6bd2\u6027\u800c\u53d7\u5230\u4e34\u5e8a\u5e94\u7528\u9650\u5236\u7684\u80cc\u666f\u4e0b\uff0cMRX-8\u7ecf\u8fc7\u7cbe\u5fc3\u7684\u7ed3\u6784\u8bbe\u8ba1\uff0c\u4e0d\u4ec5\u4fdd\u6301\u6216\u63d0\u5347\u4e86\u6cbb\u7597\u6548\u679c\uff0c\u66f4\u5728\u5b89\u5168\u6027\u65b9\u9762\u53d6\u5f97\u4e86\u663e\u8457\u8fdb\u6b65\uff0c\u5927\u5e45\u964d\u4f4e\u4e86\u8fd9\u4e9b\u6f5c\u5728\u7684\u6bd2\u6027\u98ce\u9669\u3002<\/p>\n<p>2022\u5e74MRX-8\u5df2\u5b8c\u6210\u7f8e\u56fdI\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff1b2023\u5e74MRX-8\u5b8c\u6210\u4e2d\u56fdI\u671f\u5165\u7ec4\uff0c\u5e76\u4e8e2024\u5e746\u6708\u53d1\u5e03\u4e3b\u8981\u7814\u7a76\u7ed3\u679c\u3002\u8bd5\u9a8c\u7ed3\u679c\u5747\u663e\u793a\u51fa\uff0c\u5728\u9884\u671f\u7684\u4e34\u5e8a\u7ed9\u836f\u5242\u91cf\u4e0b\uff0cMRX-8\u5728\u4eba\u4f53\u5185\u7684\u66b4\u9732\u91cf\u53ef\u671b\u5bf9\u5927\u80a0\u6746\u83cc\u3001\u7eff\u8113\u6746\u83cc\u548c\u9c8d\u66fc\u4e0d\u52a8\u6746\u83cc\u7b49\u5f15\u8d77\u7684\u611f\u67d3\u8fbe\u5230\u7406\u60f3\u7684\u7597\u6548\u3002<\/p>\n<p>\u9664\u5168\u8eab\u7ed9\u836f\u7684\u65b9\u5f0f\u5916\uff0c\u516c\u53f8\u8fd8\u8ba1\u5212\u63a2\u7d22\u5f00\u53d1MRX-8\u5438\u5165\u5242\u578b\uff0c\u53d1\u6398\u5176\u9488\u5bf9\u6027\u6cbb\u7597\u6162\u6027\u80ba\u90e8\u611f\u67d3\u7684\u4e34\u5e8a\u548c\u5546\u4e1a\u4ef7\u503c\u3002<\/p>\n<p><b>\u5173\u4e8e<\/b><b>MRX-5<\/b><b>\u53ca<\/b><b>NTM<\/b><\/p>\n<p>MRX-5\u662f\u7531\u76df\u79d1\u836f\u4e1a\u81ea\u4e3b\u7814\u53d1\u7684\u65b0\u578b\u7684\u82ef\u5511\u787c\u9178\u7c7b\u6297\u751f\u7d20\uff0c\u7528\u4e8eNTM\u5bfc\u81f4\u7684\u611f\u67d3\u3002<\/p>\n<p>NTM\u662f\u5f15\u8d77\u652f\u6269\u7684\u5e38\u89c1\u75c5\u539f\u4f53\u3002\u8fd1\u5e74\u6765\uff0cNTM\u75c5\u5448\u5feb\u901f\u589e\u591a\u8d8b\u52bf\uff0c\u5df2\u6210\u4e3a\u5a01\u80c1\u4eba\u7c7b\u5065\u5eb7\u7684\u91cd\u8981\u516c\u5171\u536b\u751f\u95ee\u9898\u4e4b\u4e00\u3002<sup>[<\/sup><sup>1] <\/sup>NTM\u5bfc\u81f4\u7684\u75be\u75c5\u4e2d\uff0c\u9e1f\u5206\u679d\u6746\u83cc\u590d\u5408\u7fa4\u548c\u8113\u80bf\u5206\u679d\u6746\u83cc\u590d\u5408\u7fa4\u611f\u67d3\u5360NTM\u75c5\u768470%-95%\u3002<sup>[<\/sup><sup>2] <\/sup>NTM \u80ba\u90e8\u611f\u67d3\u7684\u4e3b\u8981\u4e34\u5e8a\u75c7\u72b6\u5305\u62ec\u6301\u7eed\u6027\u54b3\u55fd\u3001\u54b3\u75f0\u3001\u80f8\u75db\u3001\u6c14\u5598\u3001\u4e4f\u529b\u3001\u6d88\u7626\u53ca\u840e\u9761\u4e0d\u632f\u7b49\u3002<sup>[1]<\/sup><\/p>\n<p>\u6839\u636e\u4e34\u5e8a\u524d\u6570\u636e\uff0cMRX-5\u5bf9\u5927\u591a\u6570\u5e38\u89c1\u7684NTM\u81f4\u75c5\u83cc\u90fd\u5177\u6709\u826f\u597d\u7684\u6297\u83cc\u6d3b\u6027\uff0c\u4e14\u5728\u52a8\u7269\u8bd5\u9a8c\u4e2d\u663e\u793a\u4e86\u826f\u597d\u7684\u5b89\u5168\u6027\u3002\u540c\u65f6\uff0c\u836f\u7269\u76f8\u4e92\u4f5c\u7528\u5c11\u3001\u4e0d\u6613\u8010\u836f\u3001\u53ef\u53e3\u670d\u7b49\u7279\u6027\uff0c\u4f7f\u5176\u6210\u4e3a\u6162\u6027\u611f\u67d3\u6cbb\u7597\u7684\u7406\u60f3\u5019\u9009\u836f\u7269\u3002\u76ee\u524d\uff0cMRX-5\u6b63\u5728\u8fdb\u884cI\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u6709\u671b\u4e3aNTM\u75c5\u60a3\u8005\u63d0\u4f9b\u4e00\u79cd\u5168\u65b0\u7684\u6cbb\u7597\u9009\u62e9\u3002<\/p>\n<p>\u53c2\u8003\u6587\u732e\uff1a<\/p>\n[1] \u4e2d\u534e\u533b\u5b66\u4f1a\u7ed3\u6838\u75c5\u5b66\u5206\u4f1a. \u975e\u7ed3\u6838\u5206\u679d\u6746\u83cc\u75c5\u8bca\u65ad\u4e0e\u6cbb\u7597\u6307\u5357(2020\u5e74\u7248)[J]. \u4e2d\u534e\u7ed3\u6838\u548c\u547c\u5438\u6742\u5fd7, 2020,43(11): 918-946. DOI\uff1a10.3760\/cma.j.cn112147-20200508-00570.<br \/>[2] \u9c81\u9614, \u9648\u5584\u6cfd, \u9648\u8363\u660c, \u7b49.&nbsp; \u975e\u7ed3\u6838\u5206\u679d\u6746\u83cc\u75c5\u7684\u5bbf\u4e3b\u56e0\u7d20 [J] . \u4e2d\u534e\u7ed3\u6838\u548c\u547c\u5438\u6742\u5fd7, 2022, 45(7) : 716-720. DOI: 10.3760\/cma.j.cn112147-20211210-00872.<\/p>\n<p>\u8bf4\u660e\uff1a<\/p>\n<ol type=\"1\">\n<li>\u622a\u81f3\u53d1\u7a3f\u65e5\u671f\uff0cMRX-5\u53caMRX-8\u5c1a\u672a\u5728\u56fd\u5185\u5916\u83b7\u6279\u4e0a\u5e02\u3002<\/li>\n<li>\u672c\u6587\u6240\u5305\u542b\u7684\u4efb\u4f55\u533b\u7597\u533b\u836f\u4fe1\u606f\u53ea\u4f5c\u4e3a\u79d1\u5b66\u4fe1\u606f\u63d0\u4f9b\uff0c\u4e0d\u80fd\u53d6\u4ee3\u5411\u533b\u751f\u6216\u5176\u4ed6\u6709\u8d44\u683c\u7684\u533b\u7597\u536b\u751f\u4e13\u4e1a\u4eba\u58eb\u8fdb\u884c\u7684\u54a8\u8be2\uff0c\u4e0d\u80fd\u66ff\u4ee3\u533b\u751f\u6216\u533b\u7597\u536b\u751f\u4e13\u4e1a\u4eba\u58eb\u63d0\u4f9b\u7684\u533b\u7597\u5efa\u8bae\u3002 \u672c\u6587\u4ec5\u4f5c\u4e3a\u76df\u79d1\u836f\u4e1a\u65b0\u95fb\u53d1\u5e03\uff0c\u975e\u5e7f\u544a\u7528\u9014\u3002\u76f8\u5173\u4fe1\u606f\u5e76\u975e\u9488\u5bf9\u60a3\u8005\uff0c\u4ec5\u4f9b\u533b\u7597\u536b\u751f\u4e13\u4e1a\u4eba\u58eb\u53c2\u8003\u4e4b\u7528\u3002\u76df\u79d1\u836f\u4e1a\u5bf9\u672c\u6587\u5185\u5bb9\u7684\u51c6\u786e\u6027\u3001\u65f6\u6548\u6027\u548c\u5b8c\u6574\u6027\u4e0d\u505a\u4efb\u4f55\u5f62\u5f0f\u7684\u4fdd\u8bc1\u6216\u627f\u62c5\u4efb\u4f55\u8d23\u4efb\u3002<\/li>\n<\/ol>\n<p><b><b>\u5173\u4e8e\u76df\u79d1<\/b><\/b><\/p>\n<p>\u6210\u7acb\u4e8e2007\u5e74\uff0c\u662f\u4e00\u5bb6\u4ee5\u6cbb\u7597\u611f\u67d3\u6027\u75be\u75c5\u4e3a\u6838\u5fc3\uff0c\u62e5\u6709\u5168\u7403\u81ea\u4e3b\u77e5\u8bc6\u4ea7\u6743\u548c\u56fd\u9645\u7ade\u4e89\u529b\u7684\u521b\u65b0\u578b\u751f\u7269\u533b\u836f\u4f01\u4e1a\uff0c\u81f4\u529b\u4e8e\u53d1\u73b0\u3001\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u9488\u5bf9\u672a\u6ee1\u8db3\u4e34\u5e8a\u9700\u6c42\u7684\u521b\u65b0\u836f\u7269\u3002\u81ea\u6210\u7acb\u4e4b\u521d\uff0c\u516c\u53f8\u4e00\u76f4\u79c9\u627f&quot;\u4ee5\u826f\u836f\u6c42\u826f\u6548&quot;\u7684\u7406\u5ff5\uff0c\u805a\u7126\u5168\u7403\u65e5\u76ca\u4e25\u91cd\u7684\u7ec6\u83cc\u8010\u836f\u6027\u95ee\u9898\uff0c\u4ee5\u89e3\u51b3\u4e34\u5e8a\u96be\u9898\u3001\u5dee\u5f02\u5316\u521b\u65b0\u4e3a\u6838\u5fc3\u7ade\u4e89\u529b\uff0c\u76ee\u6807\u4e3a\u4e34\u5e8a\u6700\u5e38\u89c1\u548c\u6700\u4e25\u91cd\u7684\u8010\u836f\u83cc\u611f\u67d3\u63d0\u4f9b\u66f4\u6709\u6548\u548c\u66f4\u5b89\u5168\u7684\u6cbb\u7597\u9009\u62e9\u3002\u66f4\u591a\u4fe1\u606f\uff0c\u656c\u8bf7\u8bbf\u95ee\u76df\u79d1\u836f\u4e1a\u5b98\u65b9\u7f51<a href=\"https:\/\/www.micurxchina.com\" target=\"_blank\" rel=\"nofollow noopener\">www.micurxchina.com<\/a>\uff0c\u6216\u8ba2\u9605\u76df\u79d1\u836f\u4e1a\u4e2d\u56fd\u5b98\u65b9\u5fae\u4fe1\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u76df\u79d1\u836f\u4e1a\u5728\u7b2c\u4e03\u5c4a\u4e16\u754c\u652f\u6c14\u7ba1\u6269\u5f20\u75c7\u5927\u4f1a\u4e0a\uff0c\u5c55\u793a\u4e86\u516c\u53f8\u7ba1\u7ebf\u4ea7\u54c1MRX-8\u548cMRX-5\u7684\u6700\u65b0\u7814\u7a76\u8fdb\u5c55 \u4e09\u9879\u91cd\u8981\u7814\u7a76\u7ed3\u679c\u8fdb\u4e00\u6b65\u652f\u6301\u4e86MRX-8\u548cMRX-5\u5728\u6cbb\u7597\u975e\u7ed3\u6838\u5206\u679d\u6746\u83cc\u80ba\u75c5\u548c\u94dc\u7eff\u5047\u5355\u80de\u83cc\u611f\u67d3\u7684\u6f5c\u529b \u82cf\u683c\u5170\u9093\u8fea2024\u5e747\u670817\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u4e0a\u6d77\u76df\u79d1\u836f\u4e1a\u80a1\u4efd\u6709\u9650\u516c\u53f8\uff08&quot;\u76df\u79d1\u836f\u4e1a&quot;\uff0c688373.SH\uff09\u4e8e2024\u5e747\u67084\u65e5\u81f36\u65e5\u5728\u82cf\u683c\u5170\u9093\u8fea\u4e3e\u884c\u7684\u7b2c\u4e03\u5c4a\u4e16\u754c\u652f\u6c14\u7ba1\u6269\u5f20\u75c7\u5927\u4f1a\uff08World Bronchiectasis Conference\uff0cWBC\uff09\u4e0a\uff0c\u5c55\u793a\u4e86\u516c\u53f8\u5728\u7814\u7684\u65b0\u578b\u6297\u751f\u7d20\u7ba1\u7ebf\u4ea7\u54c1MRX-8\u548cMRX-5\u7684\u6700\u65b0\u7814\u7a76\u8fdb\u5c55\u3002\u8fd9\u4e9b\u7814\u7a76\u7ed3\u679c\u4e3a\u672a\u6765\u6cbb\u7597\u975e\u7ed3\u6838\u5206\u679d\u6746\u83cc\uff08Nontuberculous Mycobacterial\uff0cNTM\uff09\u80ba\u75c5\u548c\u94dc\u7eff\u5047\u5355\u80de\u83cc\u611f\u67d3\u63d0\u4f9b\u4e86\u65b0\u7684\u5e0c\u671b\u3002 \u5927\u4f1a\u80cc\u666f \u4e16\u754c\u652f\u6c14\u7ba1\u6269\u5f20\u75c7\u5927\u4f1a\u662f\u5168\u7403\u9886\u5148\u7684\u4e13\u6ce8\u4e8e\u652f\u6c14\u7ba1\u6269\u5f20\u75c7\u7814\u7a76\u548c\u6cbb\u7597\u7684\u5b66\u672f\u4f1a\u8bae\u3002\u672c\u6b21\u5927\u4f1a\u6c47\u96c6\u4e86\u5168\u7403\u9876\u5c16\u7684\u79d1\u5b66\u5bb6\u548c\u4e34\u5e8a\u4e13\u5bb6\uff0c\u5171\u540c\u63a2\u8ba8\u652f\u6c14\u7ba1\u6269\u5f20\u75c7\u7684\u6700\u65b0\u7814\u7a76\u8fdb\u5c55\u3001\u4e34\u5e8a\u7ba1\u7406\u7b56\u7565\u4ee5\u53ca\u65b0\u7597\u6cd5\u7684\u5f00\u53d1\u3002 \u7814\u7a76\u4eae\u70b9 \u4f5c\u4e3a\u81f4\u529b\u4e8e\u5f00\u53d1\u521b\u65b0\u6297\u611f\u67d3\u836f\u7269\u7684\u751f\u7269\u533b\u836f\u4f01\u4e1a\uff0c\u76df\u79d1\u836f\u4e1a\u5728\u5927\u4f1a\u4e0a\u4ee5\u58c1\u62a5\u5f62\u5f0f\u5c55\u793a\u4e86\u4e09\u9879\u91cd\u8981\u7814\u7a76\u7ed3\u679c\uff0c\u8fd9\u4e9b\u7814\u7a76\u8fdb\u4e00\u6b65\u652f\u6301\u4e86MRX-8\u548cMRX-5\u5728\u6cbb\u7597\u7279\u5b9a\u611f\u67d3\u65b9\u5411\u7684\u6f5c\u529b\uff1a \u65b0\u578b\u591a\u9ecf\u83cc\u7d20\u6297\u751f\u7d20\u5bf9\u94dc\u7eff\u5047\u5355\u80de\u83cc\u7684\u4f53\u5916\u548c\u4f53\u5185\u6d3b\u6027\u7814\u7a76\uff08In vitro and in vivo activity of a novel antibiotic in the polymyxin class against Pseudomonas aeruginosa\uff09 MRX-8\u5bf9\u94dc\u7eff\u5047\u5355\u80de\u83cc\uff08\u5305\u62ec\u5bf9\u59a5\u5e03\u9709\u7d20\u548c\u963f\u7c73\u5361\u661f\u8010\u836f\u7684\u4e34\u5e8a\u5206\u79bb\u682a\uff09\u8868\u73b0\u51fa\u5f3a\u6548\u4f53\u5916\u6297\u83cc\u6d3b\u6027\u3002\u5728\u94dc\u7eff\u5047\u5355\u80de\u83cc\u80ba\u90e8\u611f\u67d3\u7684\u5c0f\u9f20\u6a21\u578b\u4e2d\uff0c\u5305\u62ec\u5bf9\u59a5\u5e03\u9709\u7d20\u654f\u611f\u548c\u8010\u836f\u7684\u5206\u79bb\u682a\uff0c\u901a\u8fc7\u96fe\u5316\u5438\u5165MRX-8\u6cbb\u7597\uff0c\u663e\u8457\u51cf\u5c11\u4e86\u80ba\u7ec4\u7ec7\u4e2d\u7684\u7ec6\u83cc\u8d1f\u8377\uff0c\u8868\u73b0\u51fa\u6740\u83cc\u6d3b\u6027\u3002 \u65b0\u578b\u4eae\u6c28\u9170-tRNA\u5408\u6210\u9176\u6291\u5236\u5242\u5bf9\u9e1f\u5206\u679d\u6746\u83cc\u590d\u5408\u7fa4\u7684\u4f53\u5916\u6d3b\u6027\u7814\u7a76\uff08In Vitro Activity of Novel Leucyl-tRNA Synthetase Inhibitor Against Mycobacterium Avium Complex\uff09 MRX-6038\uff08MRX-5\u4e3b\u8981\u6d3b\u6027\u4ee3\u8c22\u4ea7\u7269\uff09\u5bf9\u9e1f\u5206\u679d\u6746\u83cc\u4e34\u5e8a\u5206\u79bb\u682a\uff08\u5305\u62ec\u5bf9\u514b\u62c9\u9709\u7d20\u4e0d\u654f\u611f\u7684\u5206\u79bb\u682a\uff09\u8868\u73b0\u51fa\u5f3a\u6548\u4f53\u5916\u6297\u83cc\u6d3b\u6027\u3002\u5f53MRX-6038\u4e0e\u514b\u62c9\u9709\u7d20\u3001\u5229\u798f\u5e03\u6c40\u3001\u963f\u7c73\u5361\u661f\u548c\u4e59\u80fa\u4e01\u9187\u8054\u5408\u4f7f\u7528\u65f6\uff0c\u8fd9\u4e9b\u6807\u51c6\u6cbb\u7597\u836f\u7269\u7684\u8010\u836f\u9891\u7387\u5927\u5e45\u964d\u4f4e\u81f3\u4f4e\u4e8e6.5 &times; 10-11\u3002\u5bf9MRX-6038\u6cbb\u7597\u5206\u679d\u6746\u83cc\u80ba\u75c5\u7684\u8bc4\u4f30\u5c1a\u9700\u8fdb\u4e00\u6b65\u7814\u7a76\u3002 \u65b0\u578b\u4eae\u6c28\u9170-tRNA\u5408\u6210\u9176\u6291\u5236\u5242\u5bf9\u8113\u80bf\u5206\u679d\u6746\u83cc\u7684\u4f53\u5916\u548c\u4f53\u5185\u6d3b\u6027\u7814\u7a76\uff08In vitro and In vivo activity of a novel&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/20240717134400114796\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":0,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-114796","post","type-post","status-publish","format-standard","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/114796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=114796"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/114796\/revisions"}],"predecessor-version":[{"id":114797,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/114796\/revisions\/114797"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=114796"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=114796"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=114796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}